Advanced Search
Contact | Corporate | Help

Ph II of Capecitabine, Carboplatin & Bevacizumab for Gastroesophageal Junction & Gastric Carcinoma

Sponsors:
  • Stanford University
  • Genentech
Phases:
  • Phase II
IndicationsAcronym:
  • Stomach Cancer
Age Groups:
  • Adult
  • Senior
Gender:
Both
Names:
  • Drug: bevacizumab
  • Drug: carboplatin
  • Drug: capecitabine
Enrollment:
35

Additional information about NCT00780494.


SourceSolution © 2008-2012